NIH | National Cancer Institute | NCI Wiki  

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

12. Sykes EA, Chen J, Zheng G, Chan WC Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency. ACSNano 8:5698-5706 (2014).

20162017-0904-06 10 UT_OCI-ASykesACSNano2014v1.2.zip

...

15.  Binzel DW, Shu Y, Li H, Sun M, Zhang Q, Shu D, Guo B, Guo P. Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology. Mol Ther. 24:1267-77 (2016).

20162017-1101-28 04 OSU_UK_NDSU-DBinzelMT2016v1.2.zip

16. Senzer N, Nemunaitis J, Nemunaitis D, Bedell C, Edelman G, Barve M, Nunan R, Pirollo KF, Rait A, Chang EH. Phase I study of a systemically delivered p53 nanoparticle in advanced solid tumors. Mol Ther 21:1096-1103 (2013).

2017-02-13 MCCRC_TO_MDDH_GU_SGT-NSenzerMT2013v1.2.zip

17. Pirollo KF, Nemunaitis J, Leung PK, Nunan R, Adams J, Chang EH. Safety and Efficacy in Advanced Solid Tumors of a Targeted Nanocomplex Carrying the p53 Gene Used in Combination with Docetaxel: A Phase 1b Study. Mol Ther        24:1697-1706 (2016).

2017-03-03 GU_MCCRC_Gradalis_TO_MCDH_SGT-KPirolloMT2016v1.2.zip

18. Siefker-Radtke A, Zhang XQ, Guo CC, Shen Y, Pirollo KF, Sabir S, Leung C, Leong-Wu C, Ling CM, Chang EH, Millikan RE, Benedict WF. A Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary Cancers. Mol Ther 24:1484-1491 (2016).

2017-03-03 UTMDACC_UT_GU_SGT-ASiefker-RadtkeMT2016v1.2.zip

19. Le DHT, Lee KL, Shukla S, Commandeur U, Steinmetz NF Potato virus X, a filamentous plant viral nanoparticle for doxorubicin delivery in cancer therapy. Nanoscale 9:2348-2357 (2017).

2017-07-11 CWRU_RWTH-Aachen-DLeNanoscale2017v1.2.zip

20. He Z, Wan X, Schulz A, Bludau H, Dobrovolskaia MA, Stern ST, Montgomery SA, Yuan H, Li Z, Alakhova D,  Sokolsky M, Darr DB, Perou CM, Jordan R, Luxenhofer R, Kabanov AV. A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity. Biomaterials 101:296-309 (2016).

2018-01-12 UNC_TUD_NCL_JMWU_MSSU_LMSU-ZHeBMat2016v1.2.zip

21. Shmeeda H, Amitay Y, Gorin J, Tzemach D, Mak L, Stern ST, Barenholz Y, Gabizon A Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancer. J Drug Target. 24:878-889 (2016).

2017-09-28 SZMC_HU_NCL-HShmeedaJDT2016v1.2.zip

22. Kang T, Zhu Q, Wei D, Feng J, Yao J, Jiang T, Song Q, Wei X, Chen H, Gao X, Chen J Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis ACS Nano 11:1397-1411 (2017).

2018-01-12 FU_SJTU-TKangACSNano2017v1.2.zip

23. Chai Z, Hu X, Wei X, Zhan C, Lu L, Jiang K, Su B, Ruan H, Ran D, Fang RH, Zhang L, Lu W. A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery. J Control Release. 264:102-111 (2017).

2018-03-23 FU_UCSD-ZChaiJRC2017v1.2.zip

24. Bressler EM, Kim J, Shmueli RB, Mirando AC, Bazzazi H, Lee E, Popel AS, Pandey NB, Green JJ. Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells. J Biomed Mater Res A. 2018 (in press)

2018-04-18 AsclepiXTher-JHU-EBresselJBMR2018v1.2.zip

25. Nascimento AV, Singh A, Bousbaa H, Ferreira D, Sarmento B, Amiji MM. Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles Acta Biomat 47:71-80 (2017).

2018 06 26 CESPU_UP_NEU-ANascimentoAB2017v1.2.zip

26. Lu YJ, Lin PY, Huang PH, Kuo CY, Shalumon KT, Chen MY, Chen JP  Magnetic Graphene Oxide for Dual Targeted Delivery of Doxorubicin and Photothermal Therapy Nanomaterials 8:193 (2018).

2018 08 10 CGU_CGMH_CGUST_MCUT-YJLuNanomat2018v1.2.zip

27. Vogus DR, Evans MA, Pusuluri A, Barajas A, Zhang M, Krishnan V, Nowak M, Menegatti S, Helgeson ME,  Squires TM, Mitragotri S. A hyaluronic acid conjugate engineered to synergistically and sequentially delivery gemcitabine and doxorubicin to treat triple negative breast cancer. J Control Release 267:191-202 (2017).

2018 08 10 UCSB_HU-DVogusJCR2017v1.2.zip

 

ISA-TAB-Nano Curated Examples (ISA-TAB-Nano Version 1.1)

The following ISA-TAB-Nano curated examples are using Version 1.1 of the ISA-TAB-Nano specification.

...